ConductScience.org, home

Paper36975452

Stage III Non-Small-Cell Lung Cancer: An Overview of Treatment Options.

Petrella F and 10 others. Curr Oncol, 2023. Cited by 101 papers, by iCite.

Cite this record

ConductScience Library. Stage III Non-Small-Cell Lung Cancer: An Overview of Treatment Options. Papers, record 36975452. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36975452

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Stage III Non-Small-Cell Lung Cancer: An Overview of Treatment Options.
PubMed
Journal
Curr Oncol
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
101
iCite
Relative citation ratio, by iCite
11.1
iCite
Revised in PubMed
2023-04-06
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Petrella FFrancescohttps://orcid.org/0000-0001-5945-1576
2Rizzo SStefaniahttps://orcid.org/0000-0002-5151-0866
3Attili IIlariahttps://orcid.org/0000-0003-1333-6622
4Passaro AAntoniohttps://orcid.org/0000-0002-7575-3870
5Zilli TThomas
6Martucci FFrancesco
7Bonomo LLuca
8Del Grande FFilippohttps://orcid.org/0000-0003-1106-5830
9Casiraghi MMonicahttps://orcid.org/0000-0001-5986-7811
10De Marinis FFilippo
11Spaggiari LLorenzo

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Non-Small-Cell LungMajor topic
Lung NeoplasmsMajor topic
Humans
Neoplasm Staging
Combined Modality Therapy
Neoadjuvant Therapy

References119

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134295668International consensus on severe lung cancer-the first edition.Transl Lung Cancer Res2021https://conductscience.org/library/papers/34295668PubMed
233993258Veno-venous extra-corporeal membrane oxygenation-assisted right tracheal-sleeve pneumonectomy.Interact Cardiovasc Thorac Surg2021https://conductscience.org/library/papers/33993258PubMed
333689449Improving Care for Patients With Stage III or IV NSCLC: Learnings for Multidisciplinary Teams From the ACCC National Quality Survey.JCO Oncol Pract2021https://conductscience.org/library/papers/33689449PubMed
434165501Effect of Postoperative Radiotherapy for Patients With pIIIA-N2 Non-Small Cell Lung Cancer After Complete Resection and Adjuvant Chemotherapy: The Phase 3 PORT-C Randomized Clinical Trial.JAMA Oncol2021https://conductscience.org/library/papers/34165501PubMed
522124104Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer.J Clin Oncol2012https://conductscience.org/library/papers/22124104PubMed
628823336Salvage Surgery After Definitive Chemoradiotherapy for Non-small Cell Lung Cancer.Semin Thorac Cardiovasc Surg2017https://conductscience.org/library/papers/28823336PubMed
74170866The survival of patients with inoperable lung cancer: a large-scale randomized study of radiation therapy versus placebo.Radiology1968https://conductscience.org/library/papers/4170866PubMed
828885881Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.N Engl J Med2017https://conductscience.org/library/papers/28885881PubMed
928153512Paclitaxel-releasing mesenchymal stromal cells inhibit in vitro proliferation of human mesothelioma cells.Biomed Pharmacother2017https://conductscience.org/library/papers/28153512PubMed
1016434292Superior vena cava replacement for lung cancer using a heterologous (bovine) prosthesis: preliminary results.J Thorac Cardiovasc Surg2006https://conductscience.org/library/papers/16434292PubMed
1111071672A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group.N Engl J Med2000https://conductscience.org/library/papers/11071672PubMed
123032394Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group.Cancer1987https://conductscience.org/library/papers/3032394PubMed
1328717413Revisions to the Tumor, Node, Metastasis staging of lung cancer (8th edition): Rationale, radiologic findings and clinical implications.World J Radiol2017https://conductscience.org/library/papers/28717413PubMed
1417235046Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160).J Clin Oncol2007https://conductscience.org/library/papers/17235046PubMed
1533668021NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021.J Natl Compr Canc Netw2021https://conductscience.org/library/papers/33668021PubMed
1612177106Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019.J Clin Oncol2002https://conductscience.org/library/papers/12177106PubMed
1729338734Comparing the benefits of chemoradiotherapy and chemotherapy for resectable stage III A/N2 non-small cell lung cancer: a meta-analysis.World J Surg Oncol2018https://conductscience.org/library/papers/29338734PubMed
1816040924Metallic prosthesis: technique to avoid increase in CT radiation dose with automatic tube current modulation in a phantom and patients.Radiology2005https://conductscience.org/library/papers/16040924PubMed
1934383006Accelerated Hypofractionated Image-Guided vs Conventional Radiotherapy for Patients With Stage II/III Non-Small Cell Lung Cancer and Poor Performance Status: A Randomized Clinical Trial.JAMA Oncol2021https://conductscience.org/library/papers/34383006PubMed
2029405289Role of artificial intelligence in the care of patients with nonsmall cell lung cancer.Eur J Clin Invest2018https://conductscience.org/library/papers/29405289PubMed

See all 119 referencesDownload CSV of references

Cited by80

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 101 citations.

PMIDTitleJournalYearIn PapersSource
42981048Gramicidin Inhibits Lung Cancer Metastasis by Suppressing the ABL-MMP9 Signaling Axis.J Biochem Mol Toxicol2026https://conductscience.org/library/papers/42981048PubMed
42879405Predicting lymph node metastasis in non-small cell lung cancer using clinical and PET/CT-derived morphological features: An interpretable machine-learning study.PLoS One2026https://conductscience.org/library/papers/42879405PubMed
42720907MYBL2 promotes malignant phenotypes and M2-like macrophage polarization through CCL2 in non-small cell lung cancer.Mol Cell Biochem2026https://conductscience.org/library/papers/42720907PubMed
42675106Machine learning-based mapping of multimodal treatment allocations and prognostic implications of clinical concordance in non-small cell lung cancer.Sci Rep2026https://conductscience.org/library/papers/42675106PubMed
42630367
Alterations in peripheral blood inflammatory mediators, vascular endothelial growth factor, and serum tumor markers in advanced non-small cell lung cancer patients treated with bevacizumab combined with chemotherapy.
Am J Transl Res2026https://conductscience.org/library/papers/42630367PubMed
42610673Multidisciplinary Team Care for Early-Stage Lung Cancer in Low- and Middle-Income Countries and Emerging Economies: Current Position and Call for Action.Thorac Cancer2026https://conductscience.org/library/papers/42610673PubMed
42583046Immune-preserving radiotherapy and perioperative immunotherapy in stage III NSCLC: a narrative review of current management and future directions for IIIA/IIIB NSCLC.Transl Lung Cancer Res2026https://conductscience.org/library/papers/42583046PubMed
42562962Lactate derived from CAFs mediates H3K18la in stemness gene promoters, which promotes tumor malignant phenotype formation.Mol Genet Genomics2026https://conductscience.org/library/papers/42562962PubMed
42558266Redefining the concept of resectability in the landscape of perioperative treatments for lung cancer.Front Oncol2026https://conductscience.org/library/papers/42558266PubMed
42530845Nationwide Implementation of Neoadjuvant Nivolumab-Based Chemo-Immunotherapy for Resectable NSCLC: Surgical Outcomes from a Prospective Multicenter Study.Ann Surg Oncol2026https://conductscience.org/library/papers/42530845PubMed
42529140RATIONALE-303: Long-Term Outcomes of Tislelizumab in Previously Treated Advanced/Metastatic NSCLC.JTO Clin Res Rep2026https://conductscience.org/library/papers/42529140PubMed
42453889Effectiveness and safety of carbon ion radiotherapy for stage III non-small cell lung cancer: a single-center retrospective study.Front Oncol2026https://conductscience.org/library/papers/42453889PubMed
42449581
Efficacy and Time-Dependent Pattern of Consolidation Immunotherapy in Stage III Non-Small Cell Lung Cancer After Induction Chemoimmunotherapy and Radiotherapy: A Dual-Center Retrospective Cohort Study.
Cancers (Basel)2026https://conductscience.org/library/papers/42449581PubMed
42421998Upfront Surgery for c-Stage IIIB Non-Small Cell Lung Cancer with an Abnormally High Preoperative Serum Carcinoembryonic Antigen Level: A Case Report.Surg Case Rep2026https://conductscience.org/library/papers/42421998PubMed
42360010Exploring the Therapeutic Potential of Nobiletin in Nonsmall Cell Lung Cancer.Biomed Res Int2026https://conductscience.org/library/papers/42360010PubMed
42306763
Tumor stage, squamous histology and male sex predict positive resection margins in non-small cell lung cancer patients undergoing anatomical resection-a retrospective study from a high-volume thoracic surgery unit.
J Thorac Dis2026https://conductscience.org/library/papers/42306763PubMed
42236985Debate: why surgery should remain central in the management of locally advanced (Stage III) non-small-cell lung cancer.BJC Rep2026https://conductscience.org/library/papers/42236985PubMed
42180050Leveraging CT-based online adaptive radiotherapy for dose escalation in hypofractionated radiotherapy for locally advanced unresectable lung cancer.Front Oncol2026https://conductscience.org/library/papers/42180050PubMed
42129521Nivolumab plus chemoradiotherapy followed by nivolumab with or without ipilimumab for untreated locally advanced stage III NSCLC: a randomized phase 3 trial.Nat Cancer2026https://conductscience.org/library/papers/42129521PubMed
42074140Epithelial Integrins Coordinate Cellular Crosstalk Through the Regulation of Cytokines During Tissue Remodeling.Int J Mol Sci2026https://conductscience.org/library/papers/42074140PubMed

See all 80 cited byDownload CSV of cited by

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36975452

GET https://conductscience.org/api/papers/v1/36975452/references?page=2